An EXT1 Frameshift Deletion in a Chinese HMO Family: Hotspot and Domain Enrichment Analysis
Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)
DOI: 10.1002/mgg3.70349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 13.11.2026. Verfasst von Zoalnourain S H Salem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedicine and Health Laboratory in Shanxi Province, School of Life Science, Institutes of Biomedical Sciences, Shanxi University, Taiyuan, China. Hauptthemen laut MEDLINE: Exostoses, Multiple Hereditary, Frameshift Mutation, N-Acetylglucosaminyltransferases. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanxi Scholarship Council of China, Central Government-Guided Local Science and Technology Development Fund Project in Shanxi Province.
Abstract (Originalsprache)
Background
Hereditary multiple osteochondromas (HMO), the most prevalent hereditary skeletal tumor disorder, is caused mostly by pathogenic EXT1 and EXT2 variants. East Asian cases remain underrepresented in global variant repositories, and no statistical framework guides minimum sequencing coverage for cost‐effective first‐tier diagnosis.
Methods
Trio‐based whole‐exome sequencing was performed in a Chinese proband, his affected mother, and unaffected father, followed by bidirectional Sanger sequencing. A sliding‐window Poisson hotspot analysis was conducted on 448 curated pathogenic EXT1 coding variants from ClinVar and HGMD Professional. Variants were classified according to ACMG/AMP and ClinGen SVI PVS1 standards.
Results
A pathogenic heterozygous frameshift deletion, NM_000127.3: c.679delC (p.Arg227Aspfs*25), was identified in the proband and affected mother, but absent in the unaffected father. It was predicted to trigger nonsense‐mediated mRNA decay and classified Pathogenic (PVS1 + PM2‐Supporting + PP1‐Supporting + PP3‐Supporting). Hotspot analysis identified a primary cluster at residue 343 (4.07‐fold enrichment; FDR = 2.54 × 10 −5 ) and a secondary cluster at residues 212–221 (FDR = 0.011–0.031); 52.0% of pathogenic variants mapped to the N‐terminal glycosyltransferase domain (residues 21–350; p = 1.0 × 10 −3 ).
Conclusion
This case extends the HMO mutation spectrum in East Asian patients. Hotspot analysis provides a hypothesis‐generating rationale for domain‐guided tiered sequencing of residues 21–350, yet prospective validation and cost‐effectiveness assessments are mandatory before any clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedicine and Health Laboratory in Shanxi Province, School of Life Science, Institutes of Biomedical Sciences, Shanxi University, Taiyuan, China.
- Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, Taiyuan, China.
- Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Zoalnourain S H Salem, Zhonghua Zhao
Förderung
- Shanxi Scholarship Council of China
- Central Government-Guided Local Science and Technology Development Fund Project in Shanxi Province
Zitieren
APA
Salem, Z. S. H., Li, M., Li, C., Zhao, Y., & Zhao, Z. (2026). An EXT1 Frameshift Deletion in a Chinese HMO Family: Hotspot and Domain Enrichment Analysis. Molecular Genetics & Genomic Medicine, 14(11). https://doi.org/10.1002/mgg3.70349
Vancouver
Salem ZSH, Li M, Li C, Zhao Y, Zhao Z. An EXT1 Frameshift Deletion in a Chinese HMO Family: Hotspot and Domain Enrichment Analysis. Molecular Genetics & Genomic Medicine. 2026;14(11). doi:10.1002/mgg3.70349
BibTeX
@article{Salem2026,
author = {Salem, Zoalnourain S H and Li, Min and Li, Chao and Zhao, Yu and Zhao, Zhonghua},
title = {An EXT1 Frameshift Deletion in a Chinese HMO Family: Hotspot and Domain Enrichment Analysis},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/mgg3.70349}
}
EUVIMED